Heliad Equity Partners GmbH & Co. KGaA / Miscellaneous
Corporate news transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
++ Heliad participates with EUR 8.1m in Vanguard AG, Berlin
++ Strongly growing and highly profitable company in the health care
industry
Heliad Equity Partners has taken a holding in Vanguard AG, Berlin, through
a shareholder buyout (buyout of non-operative existing shareholders).
Vanguard (www.vanguard.de) is a constantly expanding company that is active
throughout Europe, which has specialized on high-tech services in the
health care sector and through technical innovations, especially at
hospitals, thus contributing towards cost reductions through improved
efficiency. Highly complex medical products for intervention treatment and
key-hole surgery are skilfully and safely prepared at the Vanguard high
tech centres.
Vanguard was founded in 1998 by the current management and has established
itself as the unchallenged market leader through continuous organic growth
as well as through strategic acquisitions. In the meantime, the company
currently looks after more than 1,000 clinics, of which 680 are located in
Germany. In recent years, the number of people employed by the company has
increased to over 900 employees based in five European business locations
(Germany, France, Switzerland, Great Britain and Poland) as well as in
local clinics. Apart from developing existing customer contacts, the
company is generating further growth primarily outside Germany, in
particular in France, England and Belgium. In this regard, Vanguard can
build on very stabile customer relationships: Since Vanguard is fully
integrated in the hospital processes, contractual relationships are entered
into for the long-term, which in turn enables a good planning base and
solid growth.
Where Heliad is concerned, with an investment of EUR 8.1m, Vanguard is its
largest holding to date. The transaction also clearly demonstrates the
increased market relevance of Heliad, which has very successfully placed
capital increases in the first six months of the year and also marks a
further major step on the way towards becoming one of the leading investors
for growing German companies.
Ralf Flore, a member of the board of management of Heliad, is pleased: “In
a virtually exclusive negotiating situation, we were able to participate in
one of the fastest growing and promising German companies, in particular
due to our network and the advantages that Heliad offers as an investor to
its portfolio companies. We are certain that our approach of investing in
fast growing, established companies with a strong management, offers the
best yield-risk ratio for our shareholders.”
About Heliad:
Heliad Equity Partners GmbH & Co. KGaA (German sec. No.: 604 729) is a
private equity firm concentrating on companies mainly in the
German-speaking area. Investments are made in companies that are in a
strong expansion period or a special situation. The aim is to produce a
good over-average risk/return ratio for the shareholders. The investor thus
intensively participates with Heliad in the expansion opportunities not
only of the traditional German middle class but also of aspiring German
technological companies.
Contact:
Heliad Equity Partners GmbH & Co. KGaA
Christiane Neblung
Leiterin Marketing & Kommunikation
Freiherr-vom-Stein-Straße 31
60323 Frankfurt
Tel.: +49(0)69 719 15 965 17
Fax: +49(0)69 719 15 965 17
E-Mail: christiane.neblung@sigma-capital.de
DGAP 17.08.2006
Language: English
Issuer: Heliad Equity Partners GmbH & Co. KGaA
Freiherr-vom-Stein-Straße 31
60323 Frankfurt am Main Deutschland
Phone: +49 (0)69 719 15 965 0
Fax: +49(0)69 719 15 965 11
E-mail: christiane.neblung@sigma-capital.de
WWW: www.heliad.de
ISIN: DE0006047293
WKN: 604729
Indices:
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin-Bremen, München, Stuttgart
End of News DGAP News-Service